Share

April 14, 2020; 94 (15 Supplement) Monday, April 27

Changes in Brain Activity with Antisense Oligonucleotide RG6042 Treatment in Early Manifest Huntington’s Disease (HD) (4003)

David J. Hawellek, Pilar Garces, Amir H. Meghdadi, Shani Waninger, Anne Smith, Marianne Manchester, Scott A. Schobel, Joerg F. Hipp
First published April 14, 2020,
Citation
Permissions

Make Comment

See Comments

Downloads
0

Share

Article Information

vol. 94 no. 15 Supplement 4003
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 14, 2020.
Copyright & Usage: 
© 2020

Author Disclosures

    1. David J. Hawellek1,
    2. Pilar Garces1,
    3. Amir H. Meghdadi2,
    4. Shani Waninger2,
    5. Anne Smith3,
    6. Marianne Manchester1,
    7. Scott A. Schobel4 and
    8. Joerg F. Hipp1
  1. David J. Hawellek1,
  2. Pilar Garces1,
  3. Amir H. Meghdadi2,
  4. Shani Waninger2,
  5. Anne Smith3,
  6. Marianne Manchester1,
  7. Scott A. Schobel4 and
  8. Joerg F. Hipp1
  1. 1Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel
  2. 2Advanced Brain Monitoring Inc
  3. 3Ionis Pharmaceuticals Inc
  4. 4F. Hoffmann-La Roche Ltd

Article usage

Article usage: April 2020 to February 2023

AbstractFullPdfSource
Apr 20203200Highwire
May 20205400Highwire
Jun 20201400Highwire
Jul 20202700Highwire
Aug 20202300Highwire
Sep 2020900Highwire
Oct 20203000Highwire
Nov 20201400Highwire
Dec 20203400Highwire
Jan 20211500Highwire
Feb 20212600Highwire
Mar 20213100Highwire
Apr 20212800Highwire
May 20212800Highwire
Jun 20211800Highwire
Jul 20213200Highwire
Aug 20212400Highwire
Sep 20213700Highwire
Oct 20215100Highwire
Nov 20211600Highwire
Dec 20211700Highwire
Jan 20221300Highwire
Feb 20221600Highwire
Mar 20222200Highwire
Apr 20222500Highwire
May 20222100Highwire
Jun 20221600Highwire
Jul 20222100Highwire
Aug 20221900Highwire
Sep 20221300Highwire
Oct 20221400Highwire
Nov 20222200Highwire
Dec 20221400Highwire
Jan 20231600Highwire
Feb 20231400Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me